Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021069
Filing Date
2025-11-06
Accepted
2025-11-06 16:07:39
Documents
53
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 730501
2 EX-31.1 ex31-1.htm EX-31.1 12938
3 EX-31.2 ex31-2.htm EX-31.2 12810
4 EX-32.1 ex32-1.htm EX-32.1 11934
5 GRAPHIC form10-q_001.jpg GRAPHIC 52972
  Complete submission text file 0001493152-25-021069.txt   4234050

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20250930.xsd EX-101.SCH 35766
7 XBRL CALCULATION FILE pcsa-20250930_cal.xml EX-101.CAL 33946
8 XBRL DEFINITION FILE pcsa-20250930_def.xml EX-101.DEF 158171
9 XBRL LABEL FILE pcsa-20250930_lab.xml EX-101.LAB 312237
10 XBRL PRESENTATION FILE pcsa-20250930_pre.xml EX-101.PRE 254891
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 503253
Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 251458258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)